Key payer backs Ultragenyx’ rare rickets drug at $200,000 per yearExpress Scripts’ Miller backs “responsible” price Share XKey payer backs Ultragenyx’ rare rickets drug at $200,000 per yearhttps://pharmaphorum.com/sales-marketing/key-payers-backs-ultragenyx-rare-rickets-drug-200000-per-year/